Mr. Arjun Handa - Managing Director & CEO, Claris Lifesciences
There is a lot of expectation from the Modi government, but it would be prudent not to expect overnight positives, the budget should be a strong budget with minimal populist measures, drawing the road map; for the next 5-10 years; of reduction in inflation and increase in Investments along with FDI. The key expectations in the near term are implementation of GST, revival of the investment cycle and stabilising the rupee.
Shares of CLARIS LIFESCIENCES LTD. was last trading in BSE at Rs.163.2 as compared to the previous close of Rs. 168.75. The total number of shares traded during the day was 131806 in over 2851 trades.
The stock hit an intraday high of Rs. 171.3 and intraday low of 160. The net turnover during the day was Rs. 21968575.